title: The absence of HIV mutations in cerebrospinal fluid and in peripheral blood mononuclear cells during a regimen containing Trizivir plus tenofovir.
authors.affiliation: Department of Tropical and Infectious Diseases, University of Rome Sapienza, Rome, Italy. gabriella.dettorre@uniroma1.it
authors.forename: G
authors.initials: G
authors.lastname: d'Ettorre
authors.forename: G
authors.initials: G
authors.lastname: Ceccarelli
authors.forename: O
authors.initials: O
authors.lastname: Turriziani
authors.forename: M
authors.initials: M
authors.lastname: Andreotti
authors.forename: P
authors.initials: P
authors.lastname: Massetti
authors.forename: C
authors.initials: C
authors.lastname: Rizza
authors.forename: S
authors.initials: S
authors.lastname: Vella
authors.forename: G
authors.initials: G
authors.lastname: Antonelli
authors.forename: C M
authors.initials: CM
authors.lastname: Mastroianni
authors.forename: V
authors.initials: V
authors.lastname: Vullo
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D015331:Cohort Studies; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D015497:HIV-1 / Q000187:drug effects / Q000235:genetics*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D007963:Leukocytes, Mononuclear / Q000187:drug effects; D009154:Mutation / Q000235:genetics*; D063065:Organophosphonates / Q000627:therapeutic use*; D011446:Prospective Studies; D000068698:Tenofovir; D014766:Viremia / Q000097:blood* / Q000134:cerebrospinal fluid* / Q000188:drug therapy; D015215:Zidovudine / Q000627:therapeutic use*; D000099227:Abacavir
chemical_list: D000225:Adenine; D019380:Anti-HIV Agents; D004338:Drug Combinations; D019259:Lamivudine; D063065:Organophosphonates; D000068698:Tenofovir; D015215:Zidovudine; C418262:abacavir, lamivudine, and zidovudine drug combination; D000099227:Abacavir